These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29453462)

  • 1. GQ-11: A new PPAR agonist improves obesity-induced metabolic alterations in LDLr
    Silva JC; de Oliveira EM; Turato WM; Trossini GHG; Maltarollo VG; Pitta MGR; Pitta IR; de Las Heras B; Boscá L; Rudnicki M; Abdalla DSP
    Int J Obes (Lond); 2018 Jun; 42(5):1062-1072. PubMed ID: 29453462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr(-/-) mice.
    Silva JC; César FA; de Oliveira EM; Turato WM; Tripodi GL; Castilho G; Machado-Lima A; de Las Heras B; Boscá L; Rabello MM; Hernandes MZ; Pitta MG; Pitta IR; Passarelli M; Rudnicki M; Abdalla DS
    Pharmacol Res; 2016 Feb; 104():49-60. PubMed ID: 26706782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of new thiazolidine derivatives LPSF/GQ-02 and LPSF/GQ-16 on atherosclerotic lesions in LDL receptor-deficient mice (LDLR(-/-)).
    Soares E Silva AK; de Oliveira Cipriano Torres D; Santos Rocha SW; dos Santos Gomes FO; dos Santos Silva B; Donato MA; Raposo C; Santos AC; de Lima Mdo C; Galdino SL; da Rocha Pitta I; de Souza JR; Peixoto CA
    Cardiovasc Pathol; 2013; 22(1):81-90. PubMed ID: 22795892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New indole-thiazolidine attenuates atherosclerosis in LDLr(-/-) mice.
    César FA; Rudnicki M; de Las Heras B; Boscá L; Lima MC; Pitta IR; Abdalla DS
    Vascul Pharmacol; 2015 Aug; 71():174-80. PubMed ID: 25869519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilirubin Increases Insulin Sensitivity by Regulating Cholesterol Metabolism, Adipokines and PPARγ Levels.
    Liu J; Dong H; Zhang Y; Cao M; Song L; Pan Q; Bulmer A; Adams DB; Dong X; Wang H
    Sci Rep; 2015 May; 5():9886. PubMed ID: 26017184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
    Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced pan-peroxisome proliferator-activated receptor gene and protein expression in adipose tissue of diet-induced obese mice treated with telmisartan.
    Penna-de-Carvalho A; Graus-Nunes F; Rabelo-Andrade J; Mandarim-de-Lacerda CA; Souza-Mello V
    Exp Physiol; 2014 Dec; 99(12):1663-78. PubMed ID: 25326526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daidzein regulates proinflammatory adipokines thereby improving obesity-related inflammation through PPARγ.
    Sakamoto Y; Naka A; Ohara N; Kondo K; Iida K
    Mol Nutr Food Res; 2014 Apr; 58(4):718-26. PubMed ID: 24343975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Peroxisome Proliferator-activated Receptor (PPAR)α Agonist and PPARγ Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice.
    Shiomi Y; Yamauchi T; Iwabu M; Okada-Iwabu M; Nakayama R; Orikawa Y; Yoshioka Y; Tanaka K; Ueki K; Kadowaki T
    J Biol Chem; 2015 Jun; 290(23):14567-81. PubMed ID: 25907553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monosodium glutamate neonatal intoxication associated with obesity in adult stage is characterized by chronic inflammation and increased mRNA expression of peroxisome proliferator-activated receptors in mice.
    Roman-Ramos R; Almanza-Perez JC; Garcia-Macedo R; Blancas-Flores G; Fortis-Barrera A; Jasso EI; Garcia-Lorenzana M; Campos-Sepulveda AE; Cruz M; Alarcon-Aguilar FJ
    Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):406-13. PubMed ID: 21205225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol-induced hepatic inflammation does not underlie the predisposition to insulin resistance in dyslipidemic female LDL receptor knockout mice.
    Gruben N; Funke A; Kloosterhuis NJ; Schreurs M; Sheedfar F; Havinga R; Houten SM; Shiri-Sverdlov R; van de Sluis B; Kuivenhoven JA; Koonen DP; Hofker MH
    J Diabetes Res; 2015; 2015():956854. PubMed ID: 25815343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone Improves Insulin Resistance Mediated by 10,12 Conjugated Linoleic Acid in a Male Mouse Model of Metabolic Syndrome.
    Wang S; Goodspeed L; Turk KE; Houston B; den Hartigh LJ
    Endocrinology; 2017 Sep; 158(9):2848-2859. PubMed ID: 28651330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Cannabinoid Receptor 1 Can Influence the Lipid Metabolism in Mice with Diet-Induced Obesity.
    Wei LW; Yuan ZQ; Zhao MD; Gu CW; Han JH; Fu L
    Biochemistry (Mosc); 2018 Oct; 83(10):1279-1287. PubMed ID: 30472964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-alpha,gamma-agonist improves insulin sensitivity and prevents loss of left ventricular function in obese dyslipidemic mice.
    Verreth W; Ganame J; Mertens A; Bernar H; Herregods MC; Holvoet P
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):922-8. PubMed ID: 16456093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
    Srivastava RA; Jahagirdar R; Azhar S; Sharma S; Bisgaier CL
    Mol Cell Biochem; 2006 Apr; 285(1-2):35-50. PubMed ID: 16477380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet-induced increases in adiposity, but not plasma lipids, promote macrophage infiltration into white adipose tissue.
    Coenen KR; Gruen ML; Chait A; Hasty AH
    Diabetes; 2007 Mar; 56(3):564-73. PubMed ID: 17327423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet.
    Fernandes-Santos C; Carneiro RE; de Souza Mendonca L; Aguila MB; Mandarim-de-Lacerda CA
    Nutrition; 2009; 25(7-8):818-27. PubMed ID: 19268533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.